Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAI vs IV Chemotherapy With Gemcitabine and Oxaliplatin for Locally Advanced Pancreatic Cancer
NCT02635971Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Dec 2015
- Primary completion
- Jun 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, oxaliplatin in pancreatic cancer (PC), sponsored by Fudan University. Status: unknown.
02
Drugs
gemcitabineoxaliplatin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02635971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02635971.